Updated on 20 October 2026
Join EU consortia
Head of EU Projects at Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC)
Las Palmas de Gran Canaria, Spain
About
Access to a large public healthcare network, 90+ research groups, real-world clinical settings and expertise across the health research spectrum, from clinical research and clinical trials to public health, health technology assessment and innovation implementation.
Based in the Canary Islands, FIISC connects research with healthcare practice and policy, being the research entity of the regional public healthcare service.
We are interested in joining EU consortia in the selected calls. We ensure proactive involvement in proposal writing/review and partnership building. We have long-term experience in EU projects. If the topic is pertinent, we could also consider the project's coordination.
Organisation
Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC)
R&D Institution
Las Palmas de Gran Canaria, Spain
Similar opportunities
Project cooperation
Nursing and Health Sciences Research Partner Seeking Horizon Europe Cluster 1 Health Consortium
Şengül Üzen Cura
Associate Professor of Nursing at Çanakkale Onsekiz Mart University
ÇANAKKALE, Türkiye
Project cooperation
Seeking consortium for Horizon Europe calls
- Partner seeks Consortium/Coordinator
- Destination 6: HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics
- Destination 5: HORIZON-HLTH-2027-03-TOOL-02: Advancing bio-printing of living cells for regenerative medicine
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 2: HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change
- Destination 5: HORIZON-HLTH-2027-03-TOOL-08: Towards the next generation of frontier Artificial Intelligence models for healthcare
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
- Destination 1: HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
- Destination 5: HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Destination 6: HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Destination 2: HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Olha Remeniak
Associate Professor at National Pirogov memorial medical university
Vinnytsia, Ukraine
Project cooperation
Healthcare Workforce, Critical Care Nursing and Clinical Implementation Partner
- Consortium/Coordinator seeks Partners
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 1: HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Olga Cerela-Boltunova
Clinical Nurse Researcher, Lecturer & PhD Candidate at Riga Stradins University
Riga, Latvia